课题基金 / 基金详情

PROTEASE INHIBITORS USED IN THE TREATMENT OF HIV+ INDUCE BETA-CELL

PROTEASE INHIBITORS USED IN THE TREATMENT OF HIV+ INDUCE BETA-CELL
用于治疗艾滋病毒的蛋白酶抑制剂诱导β细胞
批准号:
8168822
负责人:
Sheng Zhang
金额:
$1.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-10 至 2010-12-31

项目摘要

项目成果

Sheng Zhang的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 在艾滋病毒阳性患者的治疗中加入艾滋病毒蛋白酶抑制剂(PI),显著降低了死亡率,但也增加了代谢异常的发生率,其原因尚不清楚。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Inclusion of HIV protease inhibitors (PIs) in the treatment of people living with HIV+ has markedly decreased mortality but also increased the incidence of metabolic abnormalities, causes of which are not well understood.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis
The Roles of Huntingtin Associated Protein 40 in Huntingtin Functions and Huntington's Disease Pathogenesis
The roles of Huntingtin Associated Protein 40 in Huntingtin functions and Huntingtons disease pathogenesis